158 related articles for article (PubMed ID: 31796940)
1. SNPs within CHRNA5-A3-B4 and CYP2A6/B6, nicotine metabolite concentrations and nicotine dependence treatment success in smokers.
Hubacek JA; Kurcova I; Maresova V; Pankova A; Stepankova L; Zvolska K; Lanska V; Kralikova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Mar; 165(1):84-89. PubMed ID: 31796940
[TBL] [Abstract][Full Text] [Related]
2. SNPs within CHRNA5-A3-B4 and CYP2A6/B6 are associated with smoking dependence but not with tobacco dependence treatment outcomes in the Czech population.
Hubacek JA; Pankova A; Stepankova L; Zvolska K; Adamkova V; Lanska V; Kralikova E
Gene; 2017 Mar; 606():35-38. PubMed ID: 28069549
[TBL] [Abstract][Full Text] [Related]
3. CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users.
Zhu AZ; Renner CC; Hatsukami DK; Benowitz NL; Tyndale RF
Addiction; 2013 Oct; 108(10):1818-28. PubMed ID: 23692359
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.
Baurley JW; Edlund CK; Pardamean CI; Conti DV; Krasnow R; Javitz HS; Hops H; Swan GE; Benowitz NL; Bergen AW
Nicotine Tob Res; 2016 Sep; 18(9):1837-1844. PubMed ID: 27113016
[TBL] [Abstract][Full Text] [Related]
5. Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes.
Bandiera FC; Ross KC; Taghavi S; Delucchi K; Tyndale RF; Benowitz NL
Nicotine Tob Res; 2015 Sep; 17(9):1167-72. PubMed ID: 25555385
[TBL] [Abstract][Full Text] [Related]
6. Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence.
Lee SH; Ahn WY; Seweryn M; Sadee W
BMC Genomics; 2018 Nov; 19(1):826. PubMed ID: 30453884
[TBL] [Abstract][Full Text] [Related]
7. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.
Tyndale RF; Zhu AZ; George TP; Cinciripini P; Hawk LW; Schnoll RA; Swan GE; Benowitz NL; Heitjan DF; Lerman C;
PLoS One; 2015; 10(5):e0128109. PubMed ID: 26010901
[TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.
Yuan JM; Nelson HH; Butler LM; Carmella SG; Wang R; Kuriger-Laber JK; Adams-Haduch J; Hecht SS; Gao YT; Murphy SE
Int J Cancer; 2016 May; 138(9):2161-71. PubMed ID: 26662855
[TBL] [Abstract][Full Text] [Related]
9. Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15.
Keskitalo K; Broms U; Heliövaara M; Ripatti S; Surakka I; Perola M; Pitkäniemi J; Peltonen L; Aromaa A; Kaprio J
Hum Mol Genet; 2009 Oct; 18(20):4007-12. PubMed ID: 19628476
[TBL] [Abstract][Full Text] [Related]
10. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
Ring HZ; Valdes AM; Nishita DM; Prasad S; Jacob P; Tyndale RF; Swan GE; Benowitz NL
Pharmacogenet Genomics; 2007 Dec; 17(12):1007-15. PubMed ID: 18004205
[TBL] [Abstract][Full Text] [Related]
11. Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers.
Chenoweth MJ; Sylvestre MP; Contreras G; Novalen M; O'Loughlin J; Tyndale RF
Drug Alcohol Depend; 2016 Jan; 158():139-46. PubMed ID: 26644138
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
Chen LS; Bloom AJ; Baker TB; Smith SS; Piper ME; Martinez M; Saccone N; Hatsukami D; Goate A; Bierut L
Addiction; 2014 Jan; 109(1):128-137. PubMed ID: 24033696
[TBL] [Abstract][Full Text] [Related]
13. Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
Benowitz NL; St Helen G; Dempsey DA; Jacob P; Tyndale RF
Pharmacogenet Genomics; 2016 Jul; 26(7):340-50. PubMed ID: 27035242
[TBL] [Abstract][Full Text] [Related]
14. A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.
Loukola A; Buchwald J; Gupta R; Palviainen T; Hällfors J; Tikkanen E; Korhonen T; Ollikainen M; Sarin AP; Ripatti S; Lehtimäki T; Raitakari O; Salomaa V; Rose RJ; Tyndale RF; Kaprio J
PLoS Genet; 2015; 11(9):e1005498. PubMed ID: 26407342
[TBL] [Abstract][Full Text] [Related]
15. From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation.
Salloum NC; Buchalter ELF; Chanani S; Espejo G; Ismail MS; Laine RO; Nageeb M; Srivastava AB; Trapp N; Trillo L; Vance E; Wenzinger M; Hartz SM; David SP; Chen LS
Pharmacogenomics; 2018 Jul; 19(10):861-871. PubMed ID: 29914292
[TBL] [Abstract][Full Text] [Related]
16. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
Tanner JA; Henderson JA; Buchwald D; Howard BV; Nez Henderson P; Tyndale RF
Pharmacogenet Genomics; 2017 May; 27(5):169-178. PubMed ID: 28181923
[TBL] [Abstract][Full Text] [Related]
17. 'Smoking genes': a genetic association study.
Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
PLoS One; 2011; 6(10):e26668. PubMed ID: 22046326
[TBL] [Abstract][Full Text] [Related]
18. Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers.
Perez-Paramo YX; Watson CJW; Chen G; Thomas CE; Adams-Haduch J; Wang R; Khor CC; Koh WP; Nelson HH; Yuan JM; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):54-65. PubMed ID: 36252563
[TBL] [Abstract][Full Text] [Related]
19. Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms.
Bloom AJ; Baker TB; Chen LS; Breslau N; Hatsukami D; Bierut LJ; Goate A
Hum Mol Genet; 2014 Jan; 23(2):555-61. PubMed ID: 24045616
[TBL] [Abstract][Full Text] [Related]
20. Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking.
Stephens SH; Hartz SM; Hoft NR; Saccone NL; Corley RC; Hewitt JK; Hopfer CJ; Breslau N; Coon H; Chen X; Ducci F; Dueker N; Franceschini N; Frank J; Han Y; Hansel NN; Jiang C; Korhonen T; Lind PA; Liu J; Lyytikäinen LP; Michel M; Shaffer JR; Short SE; Sun J; Teumer A; Thompson JR; Vogelzangs N; Vink JM; Wenzlaff A; Wheeler W; Yang BZ; Aggen SH; Balmforth AJ; Baumeister SE; Beaty TH; Benjamin DJ; Bergen AW; Broms U; Cesarini D; Chatterjee N; Chen J; Cheng YC; Cichon S; Couper D; Cucca F; Dick D; Foroud T; Furberg H; Giegling I; Gillespie NA; Gu F; Hall AS; Hällfors J; Han S; Hartmann AM; Heikkilä K; Hickie IB; Hottenga JJ; Jousilahti P; Kaakinen M; Kähönen M; Koellinger PD; Kittner S; Konte B; Landi MT; Laatikainen T; Leppert M; Levy SM; Mathias RA; McNeil DW; Medland SE; Montgomery GW; Murray T; Nauck M; North KE; Paré PD; Pergadia M; Ruczinski I; Salomaa V; Viikari J; Willemsen G; Barnes KC; Boerwinkle E; Boomsma DI; Caporaso N; Edenberg HJ; Francks C; Gelernter J; Grabe HJ; Hops H; Jarvelin MR; Johannesson M; Kendler KS; Lehtimäki T; Magnusson PK; Marazita ML; Marchini J; Mitchell BD; Nöthen MM; Penninx BW; Raitakari O; Rietschel M; Rujescu D; Samani NJ; Schwartz AG; Shete S; Spitz M; Swan GE; Völzke H; Veijola J; Wei Q; Amos C; Cannon DS; Grucza R; Hatsukami D; Heath A; Johnson EO; Kaprio J; Madden P; Martin NG; Stevens VL; Weiss RB; Kraft P; Bierut LJ; Ehringer MA
Genet Epidemiol; 2013 Dec; 37(8):846-59. PubMed ID: 24186853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
